Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.275    0.025 (2.04%)
Bid:
1.20
Ask:
1.35
Spread: 0.15 (12.50%)
Market Cap: £20.07m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Holding(s) in Company

13 Jul 2009 10:46

RNS Number : 5512V
Epistem Holdings plc
13 July 2009
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Epistem Holdings Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

Helium Special Situations Fund

4. Full name of shareholder(s)  (if different from 3.):iv

Euroclear Nominees Limited

5. Date of the transaction and date on which the threshold is crossed or reached: v

26th June 2009

6. Date on which issuer notified:

26th June 2009

7. Threshold(s) that is/are crossed or reached: vi, vii

10%

  

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B1VKB224

770,503

770,503

670,503

670,503

9.4%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/  Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

670,503

9.4%

  

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Christian Benz

15. Contact telephone number:

+41 43 888 73 38

  

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name 

(including legal form of legal entities)

Epistem Holdings Plc

Contact address 

(registered office for legal entities)

48 Grafton Street, Manchester M13 9XX

Phone number & email

0161 606 7258/7244 j.rylands@epistem.co.uk

Other useful information 

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

IS Partners Investment Solutions AG on behalf of Helium Special Situations Fund

Contact address

Odeonhaus, Limmarquai 2, 8001 Zurich

Phone number & email

+41 43 888 73 38

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOSKRKSRBARR
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Returns
26th May 20267:00 amRNSBoard Changes
6th May 202611:56 amRNSHolding(s) in Company
5th May 20267:00 amRNSSussex NHS Trust transitions MT-RNR1 test to BAU
21st Apr 20267:00 amRNSNHS England commercial strategy for MT-RNR1
20th Apr 20267:00 amRNS-RInteractive Investor Hub Updates
16th Apr 20267:00 amRNSCYP2C19 kit implemented in North Bristol NHS Trust
30th Mar 20267:00 amRNSInterim Results to 31 December 2025
12th Mar 20269:52 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSHolding(s) in Company
11th Mar 20263:22 pmRNSHolding(s) in Company
11th Mar 20263:22 pmRNSHolding(s) in Company
9th Mar 202611:29 amRNSResult of General Meeting
9th Mar 20267:00 amRNSResult of Open Offer and Additional Subscriptions
24th Feb 20262:32 pmRNSHolding(s) in Company
24th Feb 202612:05 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSPublication of circular, notice of GM & timetable
13th Feb 20264:22 pmRNSCompletion of Placing
13th Feb 20262:04 pmRNSProposed Direct Subscription to raise up to £3.5m
6th Feb 20269:50 amRNSHolding(s) in Company
3rd Feb 202610:59 amRNSHolding(s) in Company
27th Jan 20262:18 pmRNSHolding(s) in Company
19th Jan 20263:01 pmRNSProposed equity raise of up to £6.0 million
31st Dec 202511:44 amRNSResult of AGM
31st Dec 202511:44 amRNSResult of AGM
18th Dec 20257:00 amRNSScotland NHS “test of change” pilot programme
11th Dec 20259:00 amRNSNew interactive investor hub
9th Dec 20253:45 pmRNSAgreement of Shareholder Loan
8th Dec 20254:00 pmRNSAnnual Report and Accounts and date of AGM
5th Dec 20257:00 amRNSFinal Results
3rd Dec 20257:00 amRNSNotice of Results
1st Dec 20253:19 pmRNSBlock Listing Returns
1st Dec 20257:00 amRNSResults presented re. NHS CYP2C19 Genotype Testing
27th Nov 202510:09 amRNSNHS implementation guide published for CYP2C19
26th Nov 20257:00 amRNSScotland national roll-out of MT-RNR1 ID Kit
19th Nov 20257:00 amRNSFurther re Shareholder Loan
4th Nov 20257:00 amRNSMT-RNR1 ID Kit in Dublin’s Rotunda Hospital
31st Oct 20257:00 amRNSPotential Shareholder Loan
29th Oct 20254:35 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSMOU with Kingdom of Saudi Arabia for MT-RNR1 ID
24th Oct 20254:30 pmRNSApplication for Listing & Total Voting Rights
15th Oct 202510:49 amRNSResult of General Meeting
10th Oct 20251:32 pmRNSHolding(s) in Company
10th Oct 20251:31 pmRNSHolding(s) in Company
10th Oct 20259:00 amRNSHolding(s) in Company
9th Oct 202510:23 amRNSFurther re Equity Financing
6th Oct 20257:00 amRNSFurther re Equity Financing
2nd Oct 20256:18 pmRNSHolding(s) in Company
1st Oct 202512:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.